Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-κB activation in experimental colitis

International Journal of Colorectal Disease

Volumn 24, Issue 2, 2009, Pages 231-237

  Lee, Jung Hee ^a,b   Lee, Bomi ^a   Lee, Hye Sung ^a   Bae, Eun Ah ^a   Lee, Hoyong ^b   Ahn, Young Tae ^b   Lim, Kwang Sei ^b   Huh, Chul Sung ^b   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Korea Yakult Co   (South Korea)

Author keywords

2 4 6 Trinitrobenzenesulfonic acid; Inflammatory bowel disease; Lactic acid bacteria; NF B; Toll like receptor 4

Indexed keywords

BETA GLUCURONIDASE; CYCLOOXYGENASE 2; CYTOKINE; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; PROBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STRAIN HEK293; COLITIS; CONTROLLED STUDY; DRUG POTENCY; EMBRYO; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INHIBITION KINETICS; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; LACTOBACILLUS SUNTORYEUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

ANIMALS; CELL LINE; COLITIS; COLON; CYCLOOXYGENASE 2; CYTOKINES; FECES; HUMANS; INFLAMMATION MEDIATORS; LACTOBACILLUS; MICE; NF-KAPPA B; TOLL-LIKE RECEPTOR 4;

EID: 58549106111     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-008-0618-6     Document Type: Article

References (37)

1. Benno P, Leijonmarck CE, Monsen U, Uribe A (1993) Functional alteration of the microflora in patients with ulcerative colitis. Scand J Gastroenterol 28:839-844
2. Berrebi D, Languepin J, Ferkdadji L, Foussat A, De Lagausie P, Paris R, Emilie D, Mougenot JF, Cezard JP, Navarro J, Peuchmaur M (2003) Cytokines, chemokine receptors, and homing molecule distribution in the rectum and stomach of pediatric patients with ulcerative colitis. J Pediatr Gastroenterol Nutr 37:300-308
3. Gorbach SL, Nahas L (1968) Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis, relationship to severity of disease and chemotherapy. Gastroenterology 54:575-587
4. Binder V (2004) Epidemiology of IBD during the twentieth century: An integrated view. Best Pract Res Clin Gastroenterol 18:463-479
5. Chandran P, Satthaporn Robins A, Eremin O (2003) Inflammatory bowel disease: Dysfunction of GALT and gut bacterial flora (II). Surgeon 1:125-136
6. Hill MJ, Drasar BS (1975) The normal colonic bacterial flora. Gut 16:318-323
7. Simon GL, Gorbach SL (1984) Intestinal flora in health and disease. Gastroenterology 86:174-193
8. Chung KT, Fulk GE, Slein MW (1975) Tryptophanase of fecal flora as a possible factor in the etiology of colon cancer. J Natl Cancer Inst 54:1073-1078
9. Ganguly NK, Kingham JG, Lloyd B, Lloyd RS, Price CP, Triger DR, Wright R (1978) Acid hydrolases in monocytes from patients with inflammatory bowel disease, chronic liver disease, and rheumatoid arthritis. Lancet 1(8073):1073-1075
10. Rhodes JM, Gallimore R, Elias E (1985) Fecal mucus degrading glycosidase in ulcerative colitis and Crohn's disease. Gut 26:761-765
11. Jung HC, Eckmann I, Yang SK, Panja A, Fierer J, Morzycka-Worblewska E, Kagnoff MF (1995) A distinct array of proinflammatory cytokine is expressed in human colon epithelia cells in response to bacterial invasion. J Clin Invest 95:55-65
12. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipolysaccharide-induced signal transduction. J Biol Chem 274:10689-10692
13. Ingalls RR, Heine H, Lien E, Yoshimura A, Glenbock D (1999) Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors. Infect Dis Clin North Am 13:341-353
14. Cario E, Pldolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68:7010-7017
15. Collins MP, Gibson GR (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69:s1052-s1057
16. Campieri M, Gionchetti P (1999) Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 116:1246-1260
17. Perdigon G, de Jorrat WEB, de Petrino SF, Valerde de Budeguer M (1991) Effect of oral administration of Lactobacillus casei on various biological functions of the host. Food Agric Immunol 3:93-102
18. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, Hosono A (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67:1421-1424
19. Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF (1998) Evidence for hypoglycemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci 81:2336-2340
20. Daniel C, Poiret S, Goudercourt D, Dennin V, Leyer G, Pot B (2006) Selecting lactic acid bacteria for their safety and functionality by use of a mouse colitis model. Appl Environ Microbiol 72:5799-5805
21. Han W, Mercenier A, Ait-Belgnaoui A, Pavan A, Lamine F, van Swam II, Kleerebezem M, Salvador-Cartier C, Hisbergues M, Bueno L, Theodorou V, Fioramonti J (2006) Improvement of an experimental colitis in rats by lactic acid bacteria producing superoxide dismutase. Inflamm Bowel Dis 12:1044-1052
22. Peran L, Sierra S, Comalada M, Lara-Villoslada F, Bailon E, Nieto A, Olivares M, Zarzuelo A, Xaus J, Galvez J (2007) A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97:96-103
23. Chung YW, Choi JH, Oh TY, Eun CS, Han DS (2007) Lactobacillus casei prevents the development of dextran sulfate sodium-induced colitis in toll-like receptor 4 mutant mice. Clin Exp Immunol 151:182-189
24. Grabig A, Pcclik D, Guzy C, Dankof A, Baumgart DC, Erckenbrecht J, Raupach B, Sonnenborn U, Eckert J, Schumann RR, Wiedenmann B, Dignass AU, Sturm A (2006) Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect Immun 74:4075-4082
25. Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J (2007) A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J Appl Microbiol 103:836-844
26. Han SY, Huh CS, Ahn YT, Lim KS, Baek YJ, Kim DH (2005) Hepatoprotective effect of lactic acid bacteria. J Microbiol Biotechnol 15:887-890
27. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS, Xu R, Inoue H, Arditi M, Dannenberg AJ, Abreu MT (2006) Cox-2 is regulated by toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. Gastroenterology 131:862-877
28. Hollenbach E, Vieth M, Rosessner A, Neumann M, Malfertheiner P, Naumann M (2005) Inhibition of RICK/Nuclear factor-kB and p38 signalling attenuates the inflammatory response in a murine model of Crohn Disease. J Biol Chem 280:14981-14988
29. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167
30. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
31. Shin YW, Bae EA, Kim SS, Lee YC, Kim DH (2005) Effect of ginsenoside Rb1 and compound K in chronic oxazolone-induced mouse dermatitis. Int Immunopharmacol 5:1183-1191
32. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewk K, Meyer zum Buschenfelde KH (1995) Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin Exp Immunol 102:448-455
33. Kruis W (2004) Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 20(suppl. 4):75-78
34. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics and prebiotics. Gastroenterology 126:1620-1633
35. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM (2007) VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol Ther 6:1449-1454
36. Bai A, Lu N, Guo Y, Fan X (2008) Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig Dis Sci 53:421-428
37. Barthet M, Dubucquoy L, Garcia S, Gasmi S, Descreumaux P, Colombel JF, Grimaud JC, Iovanna J, Dagorn JC (2003) Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol Clin Biol 27:895-900